{{Rsnum
|rsid=2206734
|Gene=CDKAL1
|Chromosome=6
|position=20694653
|Orientation=minus
|GMAF=0.2392
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CDKAL1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 3.6 | 25.9 | 70.5
| HCB | 12.7 | 51.5 | 35.8
| JPT | 14.2 | 50.4 | 35.4
| YRI | 4.1 | 42.9 | 53.1
| ASW | 3.5 | 28.1 | 68.4
| CHB | 12.7 | 51.5 | 35.8
| CHD | 19.3 | 40.4 | 40.4
| GIH | 2.0 | 37.6 | 60.4
| LWK | 10.2 | 26.9 | 63.0
| MEX | 3.4 | 41.4 | 55.2
| MKK | 5.2 | 45.8 | 49.0
| TSI | 2.9 | 24.5 | 72.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21139019
|Trait=None
|Title=A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum
|RiskAllele=
|Pval=0.000008
|OR=3.4500
|ORtxt=[2.08-5.56]
|OA=1
}}

{{PMID Auto
|PMID=22344221
|Title=Common variants at CDKAL1 and KLF9 are associated with body mass index in east Asian populations
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}